Alumis (ALMS) Cash from Financing Activities (2023 - 2025)
Alumis' (ALMS) quarterly Cash from Financing Activities came in at $1.3 million in Q4 2025, up 26260.0% year-over-year from N/an in Q4 2024, and up 26260.0% quarter-over-quarter from $5000.0 in Q4 2024.
Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has reported Cash from Financing Activities for 3 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 26260.0% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $236.5 million, a 51.97% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 99.58% from the prior year.
- Cash from Financing Activities was $1.3 million for Q4 2025 at Alumis, up from $5000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $235.2 million in Q3 2024 and troughed at $5000.0 in Q4 2024.
- A 3-year average of $74.8 million and a median of $29.7 million in 2023 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 500221.28% in 2024, down 99.98% in 2024.
- Over 3 years, Cash from Financing Activities stood at $29.7 million in 2023, then tumbled by 99.98% to $5000.0 in 2024, then soared by 26260.0% to $1.3 million in 2025.
- The last three Cash from Financing Activities figures came in at $1.3 million (Q4 2025), $5000.0 (Q4 2024), and $235.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | -1.48 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 2.34 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | -426.70 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | -1.22 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 14.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 1.30 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -181.51 Mn |
| 10 | Alumis | 966.94 Mn | 464.65 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 235.15 Mn |
| Jun 30, 2024 | 128.06 Mn |
| Mar 31, 2024 | 129.15 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Sep 30, 2023 | 47,000.00 |
Alumis Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALMS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ALMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();